Stock market week-in-review for 5 large GI companies — Sept. 18-22

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 18 to Sept. 22, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $220.24 on Sept. 18
Peaked: $227.36 on Sept. 18
Closed: $204.61 on Sept. 22
Percent change between Sept. 18 and Sept. 22: -7.09 percent

2. Exact Sciences Corp.

Opened: $42.75 on Sept. 18
Peaked: $46.09 on Sept. 22
Closed: $45.90 on Sept. 22
Percent change between Sept. 18 and Sept. 22: 7.36 percent

3. Johnson & Johnson

Opened: $134.54 on Sept. 18
Peaked: $136.65 on Sept. 18
Closed: $ 131.36 on Sept. 22
Percent change between Sept. 18 and Sept. 22: -2.36 percent

4. Synergy Pharmaceuticals

Opened: $2.72 on Sept. 18
Peaked: $2.79 on Sept. 18
Closed: $2.59 on Sept. 22
Percent change between Sept. 18 and Sept. 22: -4.77 percent

5. Valeant Pharmaceuticals

Opened: $13.93 on Sept. 18
Peaked: $14.37 on Sept. 21
Closed: $14.03 on Sept. 22
Percent change between Sept. 18 and Sept. 22: 0.71 percent

More articles on gastroenterology: 
GI leader to know: Dr. Daryl M. McClendon of Alaska Digestive and Liver Disease Clinic
12 statistics on gastroenterologist salary — $357k is median
Penn State College of Medicine taps Dr. Thomas Ma for chairmanship — 4 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months